Cubist Systematic Strategies’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-41,913
Closed -$2.78M 3551
2024
Q1
$2.78M Buy
41,913
+19,706
+89% +$1.22M 0.02% 1389
2023
Q4
$1.26M Sell
22,207
-39,189
-64% -$2.05M 0.01% 1867
2023
Q3
$3.34M Buy
+61,396
New +$3.64M 0.02% 1016
2023
Q2
Sell
-3,829
Closed -$197K 3958
2023
Q1
$197K Buy
+3,829
New +$186K ﹤0.01% 3240
2022
Q4
Sell
-6,502
Closed -$330K 4433
2022
Q3
$330K Buy
+6,502
New +$325K ﹤0.01% 3468
2022
Q2
Sell
-26,280
Closed -$1.22M 4457
2022
Q1
$1.22M Buy
26,280
+3,115
+13% +$139K 0.01% 1885
2021
Q4
$1.16M Buy
23,165
+2,903
+14% +$150K 0.01% 1805
2021
Q3
$1.08M Buy
20,262
+5,449
+37% +$307K 0.01% 1461
2021
Q2
$904K Sell
14,813
-14,911
-50% -$792K 0.01% 1652
2021
Q1
$1.45M Sell
29,724
-11,120
-27% -$521K 0.02% 1267
2020
Q4
$1.65M Buy
+40,844
New +$1.46M 0.02% 1078
2019
Q3
Sell
-15,957
Closed -$446K 2348
2019
Q2
$446K Buy
15,957
+9,181
+135% +$255K 0.01% 1559
2019
Q1
$210K Buy
+6,776
New +$181K 0.01% 1748
2017
Q4
Sell
-6,287
Closed -$235K 2010
2017
Q3
$235K Buy
+6,287
New +$214K 0.01% 1336

Other funds holding LMAT

Cubist Systematic Strategies's LMAT Position: Q2 2024 in Review

Cubist Systematic Strategies sold out of LeMaitre Vascular (LMAT) in Q2 2024, closing a stake of 41,913 shares — an estimated $2.78M sold.

Cubist Systematic Strategies first reported a position in LMAT in Q3 2017 and held it in 14 quarters. The position peaked at $3.34M in Q3 2023. 261 funds tracked by Wall St. Rank hold LMAT as of Q2 2024.

  • Cubist Systematic Strategies reported no remaining LeMaitre Vascular position as of Q2 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 41,913 LeMaitre Vascular shares in Q2 2024, an estimated $2.78M.
  • Cubist Systematic Strategies first reported a position in LeMaitre Vascular in Q3 2017 and held it in 14 quarters.
  • Cubist Systematic Strategies's LeMaitre Vascular position peaked at $3.34M in Q3 2023.
  • 261 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2024.

Based on Cubist Systematic Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.